From April 25, 2024 to June 30, 2024, the company has repurchased 6,916,163 shares, representing 0.39% for CNY 151.12 million. With this, the company has completed the repurchase of 6,916,163 shares, representing 0.39% for CNY 151.12 million under the buyback announced on April 25, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.23 CNY | -2.44% |
|
+3.67% | -33.64% |
07-04 | Pharmaron Beijing Buys Back, Applies to Delist Convertible Bonds | MT |
07-02 | Tranche Update on Pharmaron Beijing Co., Ltd.'s Equity Buyback Plan announced on April 25, 2024. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.64% | 4.24B | |
+22.15% | 46.56B | |
+45.94% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- 300759 Stock
- News Pharmaron Beijing Co., Ltd.
- Tranche Update on Pharmaron Beijing Co., Ltd.'s Equity Buyback Plan announced on April 25, 2024.